UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study

Alimentary pharmacology & therapeutics, 2010-08, Vol.32 (3), p.377-383

2010

Volltextzugriff (PDF)

Regional gastrointestinal transit times in severe ulcerative colitis

Neurogastroenterology and motility, 2016-02, Vol.28 (2), p.217-224

2016

Volltextzugriff (PDF)

Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas

Journal of dairy science, 2009-11, Vol.92 (11), p.5378-5385

2009

Volltextzugriff (PDF)

Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation

Mucosal immunology, 2016-01, Vol.9 (1), p.171-182

2016

Volltextzugriff (PDF)

Long‐term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.951-957

2018

Volltextzugriff (PDF)

High-dose vitamin D 3 supplementation decreases the number of colonic CD103 + dendritic cells in healthy subjects

European journal of nutrition, 2018-10, Vol.57 (7), p.2607

2018

Volltextzugriff (PDF)

The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon

Mucosal immunology, 2018-03, Vol.11 (2), p.449-461

2018

Volltextzugriff (PDF)

High-dose vitamin D3 supplementation decreases the number of colonic CD103+ dendritic cells in healthy subjects

European journal of nutrition, 2018-10, Vol.57 (7), p.2607-2619

2018

Volltextzugriff (PDF)

Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti‐TNF‐α Antibody Treatment in Active Inflammatory Bowel Disease

Scandinavian journal of immunology, 2014-12, Vol.80 (6), p.417-423

2014

Volltextzugriff (PDF)

Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease

Clinical and experimental immunology, 2015-07, Vol.181 (1), p.19-28

2015

Volltextzugriff (PDF)

Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL‐6 production and proliferation

Alimentary pharmacology & therapeutics, 2010-12, Vol.32 (11‐12), p.1364-1372

2010

Volltextzugriff (PDF)

Mucosal and systemic immune modulation by Trichuris trichiura in a self‐infected individual

Parasite immunology, 2017-01, Vol.39 (1), p.n/a

2017

Volltextzugriff (PDF)

MON-PP058: Randomised Clinical Trial: Casein Glycomacropeptide for Active Distal Ulcerative Colitis – A Pilot Study

Clinical nutrition (Edinburgh, Scotland), 2015-09, Vol.34, p.S149-S149

2015

Volltextzugriff (PDF)

Osteopontin, a Protein with Cytokine-like Properties, is Associated with Inflammation in Crohn's Disease

Scandinavian journal of immunology, 2007-05, Vol.65 (5), p.453-460

2007

Volltextzugriff (PDF)

FoxP3+CD4+CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease

Clinical and experimental immunology, 2005-09, Vol.141 (3), p.549-557

2005

Volltextzugriff (PDF)

Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease

The Journal of biological chemistry, 2003-05, Vol.278 (19), p.16777-16781

2003

Volltextzugriff (PDF)

Administration of panobinostat is associated with increased IL-17A mRNA in the intestinal epithelium of HIV-1 patients

Journal of Virus Eradication, 2015-12, Vol.1, p.35

2015

Volltextzugriff (PDF)

AB0917 A randomized, usual care controlled, parallel-group pragmatic clinical trial in an interdisciplinary combined dermatology–gastroenterology–rheumatology clinic; preliminary data on baseline characteristics of 128 patients and questionnaire-based qualitative data from 30 patients and 15 HCPs

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1588-1588

2022

Volltextzugriff (PDF)

Reduced numbers of mucosal DRint macrophages and increased numbers of CD103+ dendritic cells during anti-TNF-α treatment in patients with Crohn's disease

Scandinavian journal of gastroenterology, 2016-06, Vol.51 (6), p.692-699

2016

Volltextzugriff (PDF)

Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways

Clinical and experimental immunology, 2009-03, Vol.155 (3), p.487-495

2009

Volltextzugriff (PDF)

Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas1

Journal of dairy science, 2009-11, Vol.92 (11), p.5378-5385

2009

Volltextzugriff (PDF)

Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn’s Disease

Mediators of inflammation, 2018-01, Vol.2018 (2018), p.1-7

2018

Volltextzugriff (PDF)

Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease

Alimentary pharmacology & therapeutics, 2003-03, Vol.17 (5), p.703-710

2003

Volltextzugriff (PDF)

Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn’s disease

Gut, 2005-02, Vol.54 (2), p.314-5; author reply 316-6

2005

Volltextzugriff (PDF)

742 DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN'S DISEASE IN SUSTAINED, COMPLETE CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-151-S-152

2021

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(68)

Sprache

Englisch
(65)
Dänisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study

Regional gastrointestinal transit times in severe ulcerative colitis

Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas

Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation

Long‐term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study

High-dose vitamin D 3 supplementation decreases the number of colonic CD103 + dendritic cells in healthy subjects

The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon

High-dose vitamin D3 supplementation decreases the number of colonic CD103+ dendritic cells in healthy subjects

Soluble CD163, a Specific Macrophage Activation Marker, is Decreased by Anti‐TNF‐α Antibody Treatment in Active Inflammatory Bowel Disease

Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease

Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL‐6 production and proliferation

Mucosal and systemic immune modulation by Trichuris trichiura in a self‐infected individual

MON-PP058: Randomised Clinical Trial: Casein Glycomacropeptide for Active Distal Ulcerative Colitis – A Pilot Study

Osteopontin, a Protein with Cytokine-like Properties, is Associated with Inflammation in Crohn's Disease

FoxP3+CD4+CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease

Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease

Administration of panobinostat is associated with increased IL-17A mRNA in the intestinal epithelium of HIV-1 patients

Reduced numbers of mucosal DRint macrophages and increased numbers of CD103+ dendritic cells during anti-TNF-α treatment in patients with Crohn's disease

Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways

Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas1

Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn’s Disease

Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease

Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn’s disease

742 DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN'S DISEASE IN SUSTAINED, COMPLETE CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL

Suchergebnisse filtern